Silver Book Fact

Most common causes of death after AFib diagnosis

Within the first 4 months of diagnosis of atrial fibrillation, the most common cause of cardiovascular deaths are coronary artery disease (22%), heart failure (14%), and ischemic stroke (10%). After 4 months of diagnosis, coronary artery disease is responsible for 15% of deaths, heart failure is responsible for 16%, and stroke is responsible for 7%.

Miyasaka, Y, ME Barnes, KR Bailey, SS Cha, BJ Gersh, JB Seward, and TSM Tsang. Mortality Trends in Patients Diagnosed with First Atrial Fibrillation: A 21-year community- based study. J Am Coll Cardiol. 2007; 49(9): 986-92. http://content.onlinejacc.org/cgi/content/full/49/9/986

Reference

Title
Mortality Trends in Patients Diagnosed with First Atrial Fibrillation: A 21-year community- based study
Publication
J Am Coll Cardiol
Publication Date
2007
Authors
Miyasaka, Y, ME Barnes, KR Bailey, SS Cha, BJ Gersh, JB Seward, and TSM Tsang
Volume & Issue
Volume 49, Issue 9
Pages
986-92
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Depression and anxiety in AFib patients
    Around 1/3 of atrial fibrillation patients have elevated levels of depression and anxiety.  
  • Healthcare costs of atrial fibrillation
    Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations…  
  • Atrial fibrillation as a contributory cause of death
    Around 84% of all deaths with atrial fibrillation as a contributory cause are in individuals age 75 and older.  
  • Annual AFib care
    Each year AFib leads to around 350,000 hospitalizations, 5 million office visits, 276,000 emergency department visits, and 234,000 hospital outpatient department visits.  
  • Annual cost of treating privately insured patients for AFib
    The annual cost of treating privately insured patients for atrial fibrillation (AF) is $12,350 per patient— approximately 5 times greater than treating patients without AF.